Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Cerebrospinal Fluid Neurofilament Light Chain (NfL) Predicts Disease Aggressiveness in Amyotrophic Lateral Sclerosis: An Application of the D50 Disease Progression Model
Authors
Keywords
-
Journal
Frontiers in Neuroscience
Volume 15, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2021-04-06
DOI
10.3389/fnins.2021.651651
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Diagnostic-prognostic value and electrophysiological correlates of CSF biomarkers of neurodegeneration and neuroinflammation in amyotrophic lateral sclerosis
- (2020) Samir Abu-Rumeileh et al. JOURNAL OF NEUROLOGY
- A proposal for new diagnostic criteria for ALS
- (2020) Jeremy M. Shefner et al. CLINICAL NEUROPHYSIOLOGY
- Modelling disease course in amyotrophic lateral Sclerosis: pseudo-longitudinal insights from cross-sectional health-related quality of life data
- (2020) Tino Prell et al. Health and Quality of Life Outcomes
- Validation of serum neurofilaments as prognostic and potential pharmacodynamic biomarkers for ALS
- (2020) Michael Benatar et al. NEUROLOGY
- Phase 1–2 Trial of Antisense Oligonucleotide Tofersen for SOD1 ALS
- (2020) Timothy Miller et al. NEW ENGLAND JOURNAL OF MEDICINE
- Differential levels of Neurofilament Light protein in cerebrospinal fluid in patients with a wide range of neurodegenerative disorders
- (2020) C. Delaby et al. Scientific Reports
- A multi-center study of neurofilament assay reliability and inter-laboratory variability
- (2020) Elizabeth Gray et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Longitudinal biomarkers in amyotrophic lateral sclerosis
- (2020) Fen Huang et al. Annals of Clinical and Translational Neurology
- CSF Neurofilament Light Chain Elevation Predicts ALS Severity and Progression
- (2020) Qionghua Sun et al. Frontiers in Neurology
- Reaction to Endoplasmic Reticulum Stress via ATF6 in Amyotrophic Lateral Sclerosis Deteriorates With Aging
- (2019) Tino Prell et al. Frontiers in Aging Neuroscience
- Revised Airlie House consensus guidelines for design and implementation of ALS clinical trials
- (2019) Leonard H. van den Berg et al. NEUROLOGY
- NFL is a marker of treatment response in children with SMA treated with nusinersen
- (2019) Bob Olsson et al. JOURNAL OF NEUROLOGY
- Development and assessment of the inter-rater and intra-rater reproducibility of a self-administration version of the ALSFRS-R
- (2019) Leonhard A Bakker et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilaments in pre-symptomatic ALS and the impact of genotype
- (2019) Michael Benatar et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Combined use of CSF NfL and CSF TDP‐43 improves diagnostic performance in ALS
- (2019) Takashi Kasai et al. Annals of Clinical and Translational Neurology
- Neurofilament light: A candidate biomarker of pre-symptomatic ALS and phenoconversion
- (2018) Michael Benatar et al. ANNALS OF NEUROLOGY
- CSF neurofilament proteins as diagnostic and prognostic biomarkers for amyotrophic lateral sclerosis
- (2018) Daniela Rossi et al. JOURNAL OF NEUROLOGY
- C9orf72expansion is associated with accelerated decline of respiratory function and decreased survival in amyotrophic lateral sclerosis
- (2018) Gabriel Miltenberger-Miltenyi et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament Subunit L Levels in the Cerebrospinal Fluid and Serum of Patients with Amyotrophic Lateral Sclerosis
- (2018) Zhong-Ying Gong et al. Neurodegenerative Diseases
- Serum neurofilament light chain levels as a marker of upper motor neuron degeneration in patients with Amyotrophic Lateral Sclerosis
- (2018) B. Gille et al. NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY
- YKL40 in sporadic amyotrophic lateral sclerosis: cerebrospinal fluid levels as a prognosis marker of disease progression
- (2018) Pol Andrés-Benito et al. Aging-US
- Diagnostic and prognostic power of CSF Tau in amyotrophic lateral sclerosis
- (2018) Antonio Scarafino et al. JOURNAL OF NEUROLOGY
- Significance of CSF NfL and tau in ALS
- (2018) Stefanie Schreiber et al. JOURNAL OF NEUROLOGY
- Neurofilaments as biomarkers in neurological disorders
- (2018) Michael Khalil et al. Nature Reviews Neurology
- Serum neurofilament light chain in behavioral variant frontotemporal dementia
- (2018) Petra Steinacker et al. NEUROLOGY
- CSF sAPPβ, YKL-40, and NfL along the ALS-FTD spectrum
- (2018) Ignacio Illán-Gala et al. NEUROLOGY
- Chitotriosidase (CHIT1) is increased in microglia and macrophages in spinal cord of amyotrophic lateral sclerosis and cerebrospinal fluid levels correlate with disease severity and progression
- (2017) Petra Steinacker et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease
- (2017) Koen Poesen et al. NEUROLOGY
- ALS Clinical Trials Review: 20 Years of Failure. Are We Any Closer to Registering a New Treatment?
- (2017) Dmitry Petrov et al. Frontiers in Aging Neuroscience
- Cerebrospinal fluid neurofilament light concentration in motor neuron disease and frontotemporal dementia predicts survival
- (2017) Tobias Skillbäck et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Amyotrophic lateral sclerosis - frontotemporal spectrum disorder (ALS-FTSD): Revised diagnostic criteria
- (2017) Michael J. Strong et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Diagnostic and Prognostic Biomarkers in Amyotrophic Lateral Sclerosis
- (2017) Alessandra Gaiani et al. JAMA Neurology
- Multicenter immunoassay validation of cerebrospinal fluid neurofilament light: a biomarker for neurodegeneration
- (2016) Anne-Marie Miller et al. Bioanalysis
- Multicenter validation of CSF neurofilaments as diagnostic biomarkers for ALS
- (2016) Patrick Oeckl et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis
- (2015) C.-H. Lu et al. NEUROLOGY
- Levels and Age Dependency of Neurofilament Light and Glial Fibrillary Acidic Protein in Healthy Individuals and Their Relation to the Brain Parenchymal Fraction
- (2015) Mattias Vågberg et al. PLoS One
- Diagnostic timelines and delays in diagnosing amyotrophic lateral sclerosis (ALS)
- (2014) Sabrina Paganoni et al. Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration
- Development and evaluation of a clinical staging system for amyotrophic lateral sclerosis
- (2013) Adriano Chiò et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- A proposed staging system for amyotrophic lateral sclerosis
- (2012) J. C. Roche et al. BRAIN
- Elevated cerebrospinal fluid neurofilament light levels in patients with amyotrophic lateral sclerosis: a possible marker of disease severity and progression
- (2012) R. Tortelli et al. EUROPEAN JOURNAL OF NEUROLOGY
- Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study
- (2011) A. Chio et al. JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY
- Progression in ALS is not linear but is curvilinear
- (2010) Paul H. Gordon et al. JOURNAL OF NEUROLOGY
- Consensus criteria for the diagnosis of frontotemporal cognitive and behavioural syndromes in amyotrophic lateral sclerosis
- (2009) Michael J. Strong et al. Amyotrophic Lateral Sclerosis
- Neurofilament ELISA validation
- (2009) Axel Petzold et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Electrodiagnostic criteria for diagnosis of ALS
- (2008) Mamede de Carvalho et al. CLINICAL NEUROPHYSIOLOGY
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search